Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor

During malignant transformation, a growing body of mutations accumulate in cancer cells which not only drive cancer progression but also endow cancer cells with high immunogenicity. However, because one or multiple steps in cancer-immunity cycle are impaired, anti-cancer immune response is too weak...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Xianguang, Yi, Ming, Jiao, Ying, Chu, Qian, Wu, Kongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857659/
https://www.ncbi.nlm.nih.gov/pubmed/31807028
http://dx.doi.org/10.2147/OTT.S224013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857659/
https://www.ncbi.nlm.nih.gov/pubmed/31807028
http://dx.doi.org/10.2147/OTT.S224013

Ejemplares similares